| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.25B | +0.1% |
| Cost of Revenue | $1.30B | -1.0% |
| Gross Profit | $955.7M | +1.6% |
| R&D Expense | $58.4M | -0.2% |
| Operating Income | $199.3M | -12.2% |
| Interest Expense | $76.5M | -2.5% |
| Pre-tax Income | $120.9M | -18.1% |
| Income Tax | $22.3M | -32.4% |
| Net Income | $98.6M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $209.1M | -3.4% |
| Accounts Receivable | $109.4M | +3.0% |
| Inventory | $477.3M | -3.1% |
| Current Assets | $936.0M | -2.7% |
| Total Assets | $3.73B | -0.3% |
| Current Liabilities | $563.6M | +7.7% |
| Long-term Debt | $1.28B | -6.4% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $231.0M | +6.9% |
| Investing Cash Flow | -$62.4M | -23.6% |
| Financing Cash Flow | -$179.4M | -22.5% |
| -14.0% |
| EPS (Basic) | $1.98 | -11.6% |
| EPS (Diluted) | $1.97 | -10.9% |
| Total Liabilities |
| $2.15B |
| -2.4% |
| Stockholders' Equity | $1.58B | +2.8% |